2021 Italy HIV/AIDS Molecular Diagnostic Testing Market: Shares and Segment Forecasts-HIV 1/2, Combo, Ag, NAT, Western Blot, Other Confirmatory Tests

July 2021 | 250 pages | ID: 2202333A51A8EN
Venture Planning Group

Abstracts

Summary

This report presents detailed analyses of the AIDS diagnostics market in Italy. The report provides test volume and sales forecasts forHIV/HIV-1/2/Combo, HIVAg/HIV,NAT,Western Blot, HTLV-I/IIand other confirmatory tests performed in the following market segments:

• Hospitals
• Commercial/Private Laboratories
• Blood Banks

The report is available by section, and can be customized to specific information needs and budget.

In addition to test volume and sales projections, the report presents sales and market share estimates for major suppliers of AIDS tests.

Highlights

• Provides scientific views on the definition, epidemiology and etiology of AIDS and other retroviruses.
• Examines market applications of Molecular Diagnostics, Immunodiagnostics, IT and other emerging technologies.
• Reviews infectious disease testing analyzers marketed by Abbott, Beckman Coulter/Danaher, bioMerieux, Ortho-Clinical Diagnostics/J&J, Roche, Siemens, Tosoh and other suppliers.
• Profiles leading manufacturers and potential market entrants developing innovative technologies and products.
• Analyzes alternative market penetration strategies for suppliers.

Methodology

The report is based on a combination of primary and secondary information sources, including VPGMarketResearch's proprietary database developed during the course of over 100 syndicated studies and numerous proprietary single-client assignments. The database contains information on companies, technologies, products and executives worldwide. Moreover, a comprehensive review of the product and financial literature, business and technical periodicals, and pertinent industry analyst reports was conducted.

Contains 250 pages and 7 tables

Contents

I. INTRODUCTION

II. AIDS/HIV WORLDWIDE MARKET AND TECHNOLOGY OVERVIEW

A. Background
B. Diagnostic Tests: HIV-1/2/Combo, HIVAg/HIV NAT, Western Blot, HTLV-I/II
C. Vaccines and Drugs
D. Instrumentation Review and Market Needs
E. Emerging Diagnostic Technologies

III. ITALY: MARKET SIZE, GROWTH AND MAJOR SUPPLIERS' SALES AND MARKET SHARES

IV. ALTERNATIVE MARKET PENETRATION STRATEGIES

A. Internal Development
B. Collaborative Arrangements
C. University Contracts
D. Distribution Strategies for Decentralized Testing Markets
  1. Marketing Approaches
  2. Product Complexity
  3. Customer Preference
  4. Established Suppliers
  5. Emerging Suppliers
  6. Major Types of Distributors
  7. Market Segmentation

V. POTENTIAL MARKET ENTRY BARRIERS AND RISKS

A. Market Maturity
B. Cost Containment
C. Competition
D. Technological Edge and Limitations
E. Patent Protection
F. Regulatory Constraints
G. Decentralized Testing Market Challenges

VI. COMPETITIVE ASSESSMENTS

Abbott
Affymetrix
Beckman Coulter/Danaher
Becton Dickinson
bioMerieux
Bio-Rad
Cepheid
Diamedix/Erba
DiaSorin
Eiken Chemical
Elitech Group
Enzo Biochem
Fujirebio
Grifols
Hologic/Gen-Probe
ID Biomedical/GSK
Kreatch/Leica
Lonza
Ortho-Clinical Diagnostics
Qiagen
Roche
Scienion
Sequenom
SeraCare
Siemens
Takara Bio
Thermo Fisher
Wallac/PE
Wako

List Of Tables

LIST OF TABLES

Table 1. Major Companies Developing or Marketing AIDS Tests
Table 2. Italy: HIV or HIV-1/2/Combo Test Volume and Sales Forecast by Market Segment
Table 3. Italy: HIV Ag Test Volume and Sales Forecast by Market Segment
Table 4. Italy: Western Blot/Other Confirmatory Tests Volume and Sales Forecast by Market Segment
Table 5. Italy: HIV NAT Blood Screening Test Volume and Diagnostics Sales
Table 6. Italy: AIDS Diagnostics Market by Major Supplier
Table 7. Italy: HIV Blood Screening NAT Sales and Market Shares of Major Suppliers